Core Points - The company has approved a restricted stock incentive plan, granting 6.36 million shares to 120 eligible participants at a price of RMB 19.77 per share [1][2] - The total funds raised from this incentive plan amount to RMB 125,737,200, which will be used to supplement the company's working capital [3][7] - The effective period of the restricted stock is up to 48 months, with a minimum lock-up period of 12 months before any shares can be released [2][4] Restricted Stock Grant Details - The grant date for the restricted stock is September 16, 2025, with a total of 6.36 million shares being issued [1][3] - The stock grant does not exceed 1% of the company's total share capital for any individual participant and 10% for the entire incentive plan [2] - The company has completed the registration of the restricted stock with the China Securities Depository and Clearing Corporation [3][6] Financial Impact - The accounting treatment for the restricted stock will be in accordance with relevant accounting standards, impacting the company's financial statements over the vesting period [4][5] - The estimated accounting cost of the incentive plan will affect the net profit during the effective period, although the plan is expected to have a positive long-term impact on the company's performance [5]
证券代码：603014 证券简称：威高血净 公告编号：2025-030